“…Meanwhile, a new improved example is the German’s Platform for Analyzing Targetable Tumour Mutations (PLATON): a permanently open, multicenter, prospective, cohort study including bio-banking and sharing the platform infrastructure for associated substudies. 50 The platform PLATON focuses on GITC tumour molecular profiling and offers clinical investigators to select optimal clinical trials based on their molecular profile. An interactive web application in a virtual Molecular Tumour Board is also available and has already analysed 75 patients.…”